Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2014, Vol. 15 Issue (1): 16-42    DOI: 10.1631/jzus.B1300106
Reviews     
Prostate cancer: the need for biomarkers and new therapeutic targets
Juliana Felgueiras, Joana Vieira Silva, Margarida Fardilha
Laboratory of Signal Transduction, Centre for Cell Biology, Biology Department and Health Sciences Department, University of Aveiro, 3810-193 Aveiro, Portugal
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Prostate cancer (PCa) incidence and mortality have decreased in recent years. Nonetheless, it remains one of the most prevalent cancers in men, being a disquieting cause of men’s death worldwide. Changes in many cell signaling pathways have a predominant role in the onset, development, and progression of the disease. These include prominent pathways involved in the growth, apoptosis, and angiogenesis of the normal prostate gland, such as androgen and estrogen signaling, and other growth factor signaling pathways. Understanding the foundations of PCa is leading to the discovery of key molecules that could be used to improve patient management. The ideal scenario would be to have a panel of molecules, preferably detectable in body fluids, that are specific and sensitive biomarkers for PCa. In the early stages, androgen deprivation is the gold standard therapy. However, as the cancer progresses, it eventually becomes independent of androgens, and hormonal therapy fails. For this reason, androgen-independent PCa is still a major therapeutic challenge. By disrupting specific protein interactions or manipulating the expression of some key molecules, it might be possible to regulate tumor growth and metastasis formation, avoiding the systemic side effects of current therapies. Clinical trials are already underway to assess the efficacy of molecules specially designed to target key proteins or protein interactions. In this review, we address that recent progress made towards understanding PCa development and the molecular pathways underlying this pathology. We also discuss relevant molecular markers for the management of PCa and new therapeutic challenges.

Key wordsProstate cancer (PCa)      Biomarker      Androgen      Estrogen      Cell signaling pathway      Therapeutical target     
Received: 08 April 2013      Published: 04 January 2014
CLC:  R737.25  
Cite this article:

Juliana Felgueiras, Joana Vieira Silva, Margarida Fardilha. Prostate cancer: the need for biomarkers and new therapeutic targets. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 16-42.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1300106     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2014/V15/I1/16

[1] Sabrina Mattoli. Pathogenetic and prognostic roles of bloodborne fibrocytes in asthma[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(8): 651-660.
[2] Darren S. Miller, Anne Michelle Parsons, John Bresland, Paul Herde, Duc Minh Pham, Angel Tan, Hung-yao Hsu, Clive A. Prestidge, Tim Kuchel, Rezaul Begg, Syed Mahfuzul Aziz, Ross N. Butler. A simple and inexpensive enteric-coated capsule for delivery of acid-labile macromolecules to the small intestine[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(7): 586-592.
[3] Li Min, Jian-bo Cheng, Bao-lu Shi, Hong-jian Yang, Nan Zheng, Jia-qi Wang. Effects of heat stress on serum insulin, adipokines, AMP-activated protein kinase, and heat shock signal molecules in dairy cows[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(6): 541-548.
[4] Ying-ying Lu, Xian Yang, Wen-qing Chen, Zhen-yu Ju, Zhang-fei Shou, Juan Jin, Xiao-hui Zhang, Jiang-hua Chen, Hong Jiang. Proteins induced by telomere dysfunction are associated with human IgA nephropathy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(6): 566-574.
[5] Jie Ding, Hui Xu, Xiang Yin, Fu-rong Zhang, Xiao-ping Pan, Yi-an Gu, Jun-zhu Chen, Xiao-gang Guo. Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(3): 243-255.
[6] Wei-qin Jiang, Fang-fang Fu, Yang-xia Li, Wei-bin Wang, Hao-hao Wang, Hai-ping Jiang, Li-song Teng. Molecular biomarkers of colorectal cancer: prognostic and predictive tools for clinical practice[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(9): 663-675.
[7] Xiao-hui Zhai, Jie-kai Yu, Chen Lin, Li-dong Wang, Shu Zheng. Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesion[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(12): 964-971.
[8] Li Yang, Min Lin, Wen-jing Ruan, Liang-liang Dong, En-guo Chen, Xiao-hong Wu, Ke-jing Ying. Nkx2-1: a novel tumor biomarker of lung cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(11): 855-866.
[9] Jing Wu, Yi-ding Chen, Wei Gu. Urinary proteomics as a novel tool for biomarker discovery in kidney diseases[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(4): 227-237.
[10] Jun ZHANG, Xin-you XIE, Su-wen YANG, Jin WANG, Chao HE. Nicotinamide N-methyltransferase protein expression in renal cell cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(2): 136-143.
[11] Yi ZHENG, Jing ZHANG, Zhen-zhen XU,Jian-ming SHENG, Xiao-chen ZHANG, Hao-hao WANG, Xiao-dong TENG, Xiao-jiao LIU, Jiang CAO, Li-song TENG. Quantitative profiles of the mRNAs of ER-α and its novel variant ER-α36 in breast cancers and matched normal tissues[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(2): 144-150.
[12] Ching-hung LIN, Huang-chun LIEN, Fu-chang HU, Yen-shen LU, Sung-hsin KUO, Ling-chu WU, San-lin YOU, Ann-lii CHENG, King-jen CHANG, Chiun-sheng HUANG. Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(1): 1-9.
[13] Xiao-cao SHEN, Cai-xiao GU, Yi-qing QIU, Chuan-jun DU, Yan-biao FU, Jian-jun WU. Estrogen receptor expression in adrenocortical carcinoma[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2009, 10(1): 1-6.
[14] Yong MAO, Xin HUANG, Ke YU, Hai-bin QU, Chang-xiao LIU, Yi-yu CHENG. Metabonomic analysis of hepatitis B virus-induced liver failure: identification of potential diagnostic biomarkers by fuzzy support vector machine[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(6): 474-481.
[15] Li-rong ZHU, Wen-ying ZHANG, Li YU, Yan-hua ZHENG, Jun HU, Qin-ping LIAO. Proteiomic patterns for endometrial cancer using SELDI-TOF-MS[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(4): 286-290.